Superior Tissue Evolution in Slow-Degrading Scaffolds for Valvular Tissue Engineering.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cardiovascular Research

Background:

• Synthetic polymers are crucial for cardiovascular tissue regeneration scaffolds.
• Balancing scaffold degradation and tissue formation is vital for mechanical integrity.
• Fast-degrading scaffolds were hypothesized to enhance tissue formation via cellular compensation.

Purpose of the Study:

• To compare fast-degrading polyglycolic acid-poly-4-hydroxybutyrate (PGA-P4HB) and slow-degrading poly-ɛ-caprolactone (PCL) scaffolds for cardiovascular tissue engineering.
• To evaluate the impact of scaffold degradation rate on tissue amount, composition, and mechanical properties over time.
• To compare engineered tissues with native human heart valves.

Main Methods:

• Electrospun PGA-P4HB and PCL scaffolds were cultured with or without human vascular-derived cells for 6 weeks.
• Tissue formation, extracellular matrix (ECM) composition, scaffold weight, tissue-to-scaffold weight ratio, and mechanical properties were analyzed weekly.
• Comparison was made between scaffold types and native human heart valve tissues.

Main Results:

• PCL scaffolds maintained mass, while PGA-P4HB scaffolds degraded rapidly.
• Both scaffold types showed increased tissue with time when seeded; PGA-P4HB showed initial faster growth, but PCL yielded more tissue after 6 weeks.
• PCL-based tissues maintained shape and showed cell/ECM amounts comparable to native heart valves, unlike PGA-P4HB tissues.

Conclusions:

• Slow-degrading PCL scaffolds are superior to fast-degrading PGA-P4HB scaffolds for in vitro generation of organized, ECM-rich cardiovascular tissues.
• PCL scaffolds support the development of engineered tissues that retain their 3D structure and mimic native heart valve characteristics.
• Further research is needed to optimize collagen crosslinking in engineered tissues.